Literature DB >> 16837623

Effects of potent inhibitors of the retinoid cycle on visual function and photoreceptor protection from light damage in mice.

Akiko Maeda1, Tadao Maeda, Marcin Golczak, Yoshikazu Imanishi, Patrick Leahy, Ryo Kubota, Krzysztof Palczewski.   

Abstract

Regeneration of the chromophore 11-cis-retinal is essential for the generation of light-sensitive visual pigments in the vertebrate retina. A deficiency in 11-cis-retinal production leads to congenital blindness in humans; however, a buildup of the photoisomerized chromophore can also be detrimental. Such is the case when the photoisomerized all-trans-retinal is produced but cannot be efficiently cleared from the internal membrane of the outer segment discs. Sustained increase of all-trans-retinal can lead to the formation of toxic condensation products in the eye. Thus, there is a need for potent, selective inhibitors that can regulate the flux of retinoids through the metabolism pathway termed the visual (retinoid) cycle. Here we systematically study the effects of the most potent inhibitor of this cycle, retinylamine (Ret-NH2), on visual function in mice. Prolonged, sustainable, but reversible suppression of the visual function was observed by Ret-NH2 as a result of its storage in a prodrug form, N-retinylamides. Direct comparison of other inhibitors such as fenretinide and 13-cis-retinoic acid showed multiple advantages of Ret-NH2 and its amides, including a higher potency, specificity, and lower transcription activation. Our results also revealed that mice treated with Ret-NH2 were completely resistant to the light-induced retina damage. As an experimental tool, Ret-NH2 allows the replacement of the native chromophore with synthetic analogs in wild-type mice to better understand the function of the chromophore in the activation of rhodopsin and its metabolism through the retinoid cycle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837623      PMCID: PMC4106413          DOI: 10.1124/mol.106.026823

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  40 in total

1.  Massive light-driven translocation of transducin between the two major compartments of rod cells: a novel mechanism of light adaptation.

Authors:  Maxim Sokolov; Arkady L Lyubarsky; Katherine J Strissel; Andrey B Savchenko; Viktor I Govardovskii; Edward N Pugh; Vadim Y Arshavsky
Journal:  Neuron       Date:  2002-03-28       Impact factor: 17.173

Review 2.  Confronting complexity: the interlink of phototransduction and retinoid metabolism in the vertebrate retina.

Authors:  J K McBee; K Palczewski; W Baehr; D R Pepperberg
Journal:  Prog Retin Eye Res       Date:  2001-07       Impact factor: 21.198

3.  Blinded by the light.

Authors:  Samuel G Jacobson; Roderick R McInnes
Journal:  Nat Genet       Date:  2002-10       Impact factor: 38.330

4.  Delayed dark-adaptation and lipofuscin accumulation in abcr+/- mice: implications for involvement of ABCR in age-related macular degeneration.

Authors:  N L Mata; R T Tzekov; X Liu; J Weng; D G Birch; G H Travis
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-07       Impact factor: 4.799

5.  The Rpe65 Leu450Met variation increases retinal resistance against light-induced degeneration by slowing rhodopsin regeneration.

Authors:  A Wenzel; C E Reme; T P Williams; F Hafezi; C Grimm
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

6.  Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration.

Authors:  Roxana A Radu; Nathan L Mata; Steven Nusinowitz; Xinran Liu; Paul A Sieving; Gabriel H Travis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-01       Impact factor: 11.205

7.  Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration.

Authors:  N L Mata; J Weng; G H Travis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

8.  Evaluation of the role of the retinal G protein-coupled receptor (RGR) in the vertebrate retina in vivo.

Authors:  Tadao Maeda; J Preston Van Hooser; Carola A G G Driessen; Sławomir Filipek; Jacques J M Janssen; Krzysztof Palczewski
Journal:  J Neurochem       Date:  2003-05       Impact factor: 5.372

9.  Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness.

Authors:  J P Van Hooser; T S Aleman; Y G He; A V Cideciyan; V Kuksa; S J Pittler; E M Stone; S G Jacobson; K Palczewski
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

10.  Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy.

Authors:  P A Sieving; P Chaudhry; M Kondo; M Provenzano; D Wu; T J Carlson; R A Bush; D A Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  52 in total

Review 1.  Retinoids for treatment of retinal diseases.

Authors:  Krzysztof Palczewski
Journal:  Trends Pharmacol Sci       Date:  2010-06       Impact factor: 14.819

2.  Deuterium enrichment of vitamin A at the C20 position slows the formation of detrimental vitamin A dimers in wild-type rodents.

Authors:  Yardana Kaufman; Li Ma; Ilyas Washington
Journal:  J Biol Chem       Date:  2010-11-12       Impact factor: 5.157

3.  Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment.

Authors:  Konstantin Petrukhin
Journal:  Drug Discov Today Ther Strateg       Date:  2013

4.  Metabolic basis of visual cycle inhibition by retinoid and nonretinoid compounds in the vertebrate retina.

Authors:  Marcin Golczak; Akiko Maeda; Grzegorz Bereta; Tadao Maeda; Philip D Kiser; Silke Hunzelmann; Johannes von Lintig; William S Blaner; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2008-01-14       Impact factor: 5.157

5.  Evaluation of potential therapies for a mouse model of human age-related macular degeneration caused by delayed all-trans-retinal clearance.

Authors:  Tadao Maeda; Akiko Maeda; Melissa Matosky; Kiichiro Okano; Satsumi Roos; Johnny Tang; Krzysztof Palczewski
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-06-03       Impact factor: 4.799

6.  Phase ii, randomized, placebo-controlled, 90-day study of emixustat hydrochloride in geographic atrophy associated with dry age-related macular degeneration.

Authors:  Pravin U Dugel; Roger L Novack; Karl G Csaky; Preston P Richmond; David G Birch; Ryo Kubota
Journal:  Retina       Date:  2015-06       Impact factor: 4.256

7.  New GABA modulators protect photoreceptor cells from light-induced degeneration in mouse models.

Authors:  Rebecca M Schur; Songqi Gao; Guanping Yu; Yu Chen; Akiko Maeda; Krzysztof Palczewski; Zheng-Rong Lu
Journal:  FASEB J       Date:  2018-01-24       Impact factor: 5.191

8.  Ligand Binding Induces Conformational Changes in Human Cellular Retinol-binding Protein 1 (CRBP1) Revealed by Atomic Resolution Crystal Structures.

Authors:  Josie A Silvaroli; Jason M Arne; Sylwia Chelstowska; Philip D Kiser; Surajit Banerjee; Marcin Golczak
Journal:  J Biol Chem       Date:  2016-02-21       Impact factor: 5.157

9.  Fundus albipunctatus in a 6-year old girl due to compound heterozygous mutations in the RDH5 gene.

Authors:  Alessandro Iannaccone; Salvatore A Tedesco; Kevin T Gallaher; Hiroyuki Yamamoto; Steve Charles; Thaddeus P Dryja
Journal:  Doc Ophthalmol       Date:  2007-05-03       Impact factor: 2.379

10.  Single doses of all-trans-N-retinylacetamide slow down the ERG amplitude recovery after bleaching in rats.

Authors:  Andre Messias; Eberhart Zrenner; Radouil Tzekov; David McGee; Tobias Peters; Barbara Wilhelm; Aneta Baryluk; Ryo Kubota; Florian Gekeler
Journal:  Doc Ophthalmol       Date:  2009-12-11       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.